Da Yang
- University of Pittsburgh · Pharmacology (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #22,805
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12340569Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-8336-9457Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
NIH Funding · FY2026
Linked Award Amount
$770.6K
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#22,805
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Da Yang as a PI. Multi-PI records show the full award amount for context.
- 5R01CA282704-04R01Contact PIEnhancer RNAs Boost MYC-Chromatin Interaction to Regulate Gene Expression and TumorigenesisUniversity of Pittsburgh · Pharmacology (NIH department code)$399.1Kaward amount
- 5R01CA272866-04R01Contact PILncRNA EPIC1 induces immunotherapy resistance by activating EZH2 in breast cancerUniversity of Pittsburgh · Pharmacology (NIH department code)$371.5Kaward amount
Award organization
Organizations that administered FY2026 awards listing Da Yang as a PI.
FY2026 award administered by University of Pittsburgh (PA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Pittsburgh
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder